| Mapping and predicting mortality from systemic sclerosis M Elhai, C Meune, M Boubaya, J Avouac, E Hachulla, A Balbir-Gurman, ... Annals of the rheumatic diseases 76 (11), 1897-1905, 2017 | 531 | 2017 |
| Trends in mortality in patients with systemic sclerosis over 40 years: a systematic review and meta-analysis of cohort studies M Elhai, C Meune, J Avouac, A Kahan, Y Allanore Rheumatology 51 (6), 1017-1026, 2012 | 506 | 2012 |
| Mortality in rheumatoid arthritis over the last fifty years: systematic review and meta-analysis S Dadoun, N Zeboulon-Ktorza, C Combescure, M Elhai, S Rozenberg, ... Joint Bone Spine 80 (1), 29-33, 2013 | 374 | 2013 |
| Outcomes of patients with systemic sclerosis-associated polyarthritis and myopathy treated with tocilizumab or abatacept: a EUSTAR observational study M Elhai, M Meunier, M Matucci-Cerinic, B Maurer, G Riemekasten, ... Annals of the rheumatic diseases 72 (7), 1217-1220, 2013 | 223* | 2013 |
| Outcomes of patients with systemic sclerosis treated with rituximab in contemporary practice: a prospective cohort study M Elhai, M Boubaya, O Distler, V Smith, M Matucci-Cerinic, JJA Sancho, ... Annals of the rheumatic diseases 78 (7), 979-987, 2019 | 200 | 2019 |
| A gender gap in primary and secondary heart dysfunctions in systemic sclerosis: a EUSTAR prospective study M Elhai, J Avouac, UA Walker, M Matucci-Cerinic, G Riemekasten, P Airò, ... Annals of the rheumatic diseases 75 (1), 163-169, 2016 | 139 | 2016 |
| Performance of candidate serum biomarkers for systemic sclerosis–associated interstitial lung disease M Elhai, AM Hoffmann‐Vold, J Avouac, S Pezet, A Cauvet, A Leblond, ... Arthritis & rheumatology 71 (6), 972-982, 2019 | 127 | 2019 |
| Ultrasonographic hand features in systemic sclerosis and correlates with clinical, biologic, and radiographic findings M Elhai, H Guerini, R Bazeli, J Avouac, V Freire, JL Drapé, A Kahan, ... Arthritis care & research 64 (8), 1244-1249, 2012 | 104 | 2012 |
| Systemic sclerosis at the crossroad of polyautoimmunity M Elhai, J Avouac, A Kahan, Y Allanore Autoimmunity reviews 12 (11), 1052-1057, 2013 | 90 | 2013 |
| Systemic sclerosis: recent insights M Elhai, J Avouac, A Kahan, Y Allanore Joint Bone Spine 82 (3), 148-153, 2015 | 86 | 2015 |
| Targeting IL-6 by both passive or active immunization strategies prevents bleomycin-induced skin fibrosis L Desallais, J Avouac, M Fréchet, M Elhai, R Ratsimandresy, M Montes, ... Arthritis research & therapy 16, 1-12, 2014 | 86 | 2014 |
| Systematic switch from innovator infliximab to biosimilar infliximab in inflammatory chronic diseases in daily clinical practice: the experience of Cochin University Hospital … J Avouac, A Moltó, V Abitbol, A Etcheto, A Salcion, L Gutermann, C Klotz, ... Seminars in Arthritis and Rheumatism 47 (5), 741-748, 2018 | 75 | 2018 |
| Hand and wrist involvement in systemic sclerosis: US features V Freire, R Bazeli, M Elhai, R Campagna, É Pessis, J Avouac, Y Allanore, ... Radiology 269 (3), 824-830, 2013 | 74 | 2013 |
| Abatacept for refractory juvenile idiopathic arthritis–associated uveitis: two new cases. Comment on the article by Zulian et al M Elhai, CJ Deslandre, A Kahan Arthritis Care & Research 63 (2), 307-308, 2011 | 70 | 2011 |
| Treatment with abatacept prevents experimental dermal fibrosis and induces regression of established inflammation-driven fibrosis M Ponsoye, C Frantz, N Ruzehaji, C Nicco, M Elhai, B Ruiz, A Cauvet, ... Annals of the Rheumatic Diseases 75 (12), 2142-2149, 2016 | 67 | 2016 |
| Radiological cervical spine involvement in young adults with polyarticular juvenile idiopathic arthritis M Elhai, J Wipff, R Bazeli, V Freire, A Feydy, J Drape, P Quartier, A Kahan, ... Rheumatology 52 (2), 267-275, 2013 | 65 | 2013 |
| OX40L blockade protects against inflammation-driven fibrosis M Elhai, J Avouac, AM Hoffmann-Vold, N Ruzehaji, O Amiar, B Ruiz, ... Proceedings of the National Academy of Sciences 113 (27), E3901-E3910, 2016 | 59 | 2016 |
| Circulating lung biomarkers in idiopathic lung fibrosis and interstitial lung diseases associated with connective tissue diseases: Where do we stand? M Elhai, J Avouac, Y Allanore Seminars in arthritis and rheumatism 50 (3), 480-491, 2020 | 57 | 2020 |
| Combined effect of genetic background and gender in a mouse model of bleomycin-induced skin fibrosis N Ruzehaji, J Avouac, M Elhai, M Frechet, C Frantz, B Ruiz, JH Distler, ... Arthritis research & therapy 17, 1-12, 2015 | 50 | 2015 |
| IgG4-related skin disease successfully treated by thalidomide: a report of 2 cases with emphasis on pathological aspects S Ingen-Housz-Oro, N Ortonne, M Elhai, Y Allanore, P Aucouturier, ... JAMA dermatology 149 (6), 742-747, 2013 | 44 | 2013 |
